Characteristics of the 14 patients analysed
| Female | 4 (29%) |
| Age years | 55 (13) |
| BMI kg·m−2 | 31.1 (4.0) |
| Neck circumference cm | 41.8 (6.1) |
| Waist circumference cm | 112.5 (12.3) |
| OSA treatment | |
| CPAP | 4 (29%) |
| Oral appliance | 2 (14%) |
| Comorbidities | |
| Hypertension | 5 (35%) |
| Diabetes | 2 (14%) |
| Hypercholesterolaemia | 2 (14%) |
| Rheumatoid arthritis | 1 (7%) |
| Medications | |
| ACE-IARB | 4 (29%) |
| Diuretic | 1 (7%) |
| Beta blockers | 1 (7%) |
| Ca++ channel antagonist | 2 (14%) |
| Antilipidaemic | 2 (14%) |
| Oral hypoglycaemic | 1 (7%) |
| NSAIDs | 1 (7%) |
Data are presented as or median (interquartile range), unless otherwise stated. BMI: body mass index; OSA: obstructive sleep apnoea; CPAP: continuous positive airway pressure; ACE-I: angiotensin-converting enzyme inhibitor; ARB: angiotensin receptor blocker; NSAIDs: non-steroidal anti-inflammatory drugs.